In Hamburg wird erstmals ein Patient behandelt, der sich in Westafrika mit dem Ebola-Virus angesteckt hat. "Der Patient ist in einem Zustand, der hoffen lässt", sagte Stefan Schmiedel, betreuender Oberarzt am Universitätsklinikum Hamburg-Eppendorf (UKE), auf einer Pressekonferenz. Derzeit sei nicht geplant, experimentelle Therapien bei der Behandlung des Patienten einzusetzen. "Wir glauben, dass die Basismaßnahmen ausreichen", so Schmiedel.
Der senegalesische Epidemiologe war für die Weltgesundheitsorganisation WHO in Sierra Leone im Einsatz. Nach Bekanntwerden seiner Infektion hat die WHO kurzfristig alle Helfer aus dem Labor in Kaihalun abgezogen.
Zu seiner Therapie gehört jetzt, Symptome wie Durchfall, Übelkeit und Fieber zu behandeln, Schmerzen zu therapieren und den Flüssigkeitshaushalt zu stabilisieren. Ein zugelassenes Ebola-Medikament gibt es bisher nicht. Bei seiner Ankunft in Hamburg konnte der Patient - zum Teil gestützt von Medizinern - selbstständig in den Isolierrettungswagen steigen.
Entscheidung innerhalb von vier Stunden gefallen
Die Bitte der WHO, den Senegalesen nach Deutschland zu holen, ging laut Aussage auf der Pressekonferenz bereits am Samstagabend in Hamburg ein. Innerhalb von vier Stunden wurden demnach alle zuständigen Behörden verständigt und hatten eingewilligt.
In Hamburg, a patient is first treated, who has been infected in West Africa with the Ebola virus. "The patient is in a state that gives us hope," said Stefan Schmiedel, supervising senior physician at the University Hospital Hamburg-Eppendorf (UKE), at a press conference. Currently there are no plans to use experimental therapies in the treatment of the patient. "We believe that the basic measures are sufficient," says Schmiedel. The Senegalese epidemiologist was for the World Health Organization in Sierra Leone in use. After becoming aware of his infection, the WHO has withdrawn the short term all the helpers of the laboratory in Kaihalun. To his therapy belongs now to treat symptoms such as diarrhea, nausea and fever, to treat pain and stabilize the fluid balance. An approved Ebola drug does not yet exist. Upon his arrival in Hamburg, the patient could - having regard to the part of physicians - independent increase in the Isolierrettungswagen. Like decision within four hours WHO request to bring the Senegalese to Germany, went according to a statement at the press conference on Saturday evening in Hamburg. Accordingly, all competent authorities were notified within four hours and had consented.
Sorry about the spacing, just copied it.
So, it's confirmed that its out now?
TORONTO -- Canada is in the process of evacuating its three-member mobile laboratory team from Sierra Leone over concerns for the safety of the scientists as the World Health Organization investigates how an African doctor who worked at the same field unit as the Canadians contracted Ebola.
The Public Health Agency of Canada said late Tuesday that the team is being recalled to Canada after people at the hotel complex where they were staying were diagnosed with Ebola. The agency said the Canadians do not appear to be sick but will be in voluntary isolation both on their trip home and after they return to the country.
The WHO's director of communications, Christy Feig, said the organization is investigating how the doctor, a Senegalese epidemiologist, became infected with the virus. The unit where he and the Canadians were working did not treat patients; it was a support operation for a nearby treatment centre operated by Medecins Sans Frontieres.
The Senegalese doctor has been evacuated to Hamburg, Germany for care. He is the first person working on an Ebola outbreak through the WHO's Global Outbreak Alert and Response Network to have contracted the disease.
The Public Health Agency's statement did not elaborate on why the federal government felt the situation at Kailahun was significant enough to required that the scientists be brought back to Canada.
The agency did say the Canadians had no contact with the sick individuals at the hotel and are not themselves showing symptoms.
Read more: www.ctvnews.ca...